Dalagon, Apple Grace P.
HRN: 16-94-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 1.5GM (VIAL)
06/20/2022
06/27/2022
IVTT
1.5g
Q8
Pulmonary Infection
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes